Glow Blend

The most striking feature after dissolving: the solution is bluish. That comes from the copper complex of GHK-Cu, which makes up by far the largest share of this mixture. Alongside the copper tripeptide the vial contains BPC-157 and TB-500, each in a smaller amount.

Why these three? In research, each peptide stands for a different level of tissue repair:

• GHK-Cu: building the matrix. In models it stimulates the formation of collagen and glycosaminoglycans and modulates the metalloproteinases that break tissue down.
• BPC-157: connective tissue and mucosa. Tendons, gut lining and the signalling chain via nitric oxide are its focus.
• TB-500: the cellular level. By binding actin it promotes cell migration and new vessel formation and acts on inflammatory signals.

Together the combination ranks among the most frequently chosen multi-peptide approaches in regenerative research whenever several complementary repair routes are to be observed in the same model. Compared with three separate vials, the mixture saves steps: reconstitute once, one vial in the set-up, one fixed ratio of amounts.

On handling: the powder arrives freeze-dried and is dissolved with bacteriostatic water. The finished solution belongs in the refrigerator; for longer storage, freezing is possible.

What does not exist: studies of the finished mixture. Every statement comes from research on the three individual peptides. If you work through the sources, each of them deals with a single ingredient.

GHK-Cu, BPC-157 and TB-500 are each regarded as mildly tolerated in the preclinical literature, and on current knowledge this carries over to the combination. Long-term human studies are missing for all three; the favourable picture rests on animal models and short periods of experience.

• Injection site: redness, a feeling of pressure or a brief irritation, the most frequent observation with subcutaneous administration.
• Copper share: the high GHK-Cu concentration can slightly intensify local irritation at the injection site compared with copper-free peptide solutions.
• New vessel growth via TB-500: a theoretical concern that stimulated angiogenesis also supplies existing abnormal tissue is debated but not proven.

This summary is no substitute for medical advice.

• GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration - signalling routes through which the GHK share acts in skin.
• Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing - critical review of the BPC-157 share: positive findings in tendon, ligament and muscle, almost only from rodent studies, human data open.
• Progress on the Function and Application of Thymosin β4 - state of research on the TB-500 share.
• Regenerative and Protective Actions of GHK-Cu in the Light of New Gene Data - gene expression data on GHK-Cu.
• Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians - sports medicine primer on all three peptides: mostly preclinical evidence, no clinical data on amount, duration and safety, and the finished mixture is not covered.